uz
Feedback
Introduction Modules | سنة أولى طب

Introduction Modules | سنة أولى طب

Kanalga Telegram’da o‘tish

Data Introduction Modules لمشاركة القناة - https://t.me/Introduction_Modules البوت - https://t.me/Introduction_ModulesBot القناة الرئيسية - @Medicine_Way2

Ko'proq ko'rsatish

📈 Telegram kanali Introduction Modules | سنة أولى طب analitikasi

Introduction Modules | سنة أولى طب (@introduction_modules) Arab til segmentidagi kanali faol ishtirokchi. Hozirda hamjamiyat 27 086 obunachidan iborat bo'lib, Tibbiyot toifasida 761-o'rinni va Misr mintaqasida 677-o'rinni egallagan.

📊 Auditoriya ko‘rsatkichlari va dinamika

невідомо sanasidan buyon loyiha tez o‘sib, 27 086 obunachiga ega bo‘ldi.

31 Avgust, 2026 dagi oxirgi ma’lumotlarga ko‘ra kanal barqaror faollikka ega. Oxirgi 30 kunda obunachilar soni 885 ga, so‘nggi 24 soatda esa 12 ga o‘zgardi va umumiy qamrov yuqori darajada qolmoqda.

  • Tasdiqlash holati: Tasdiqlanmagan
  • Jalb etish (ER): Auditoriya o‘rtacha 3.31% darajada jalb etiladi. Nashrdan keyingi dastlabki 24 soatda kontent odatda umumiy obunachilar sonining 1.19% ini tashkil etuvchi reaksiyalarni to‘playdi.
  • Post qamrovi: Har bir post o‘rtacha 895 marta ko‘riladi; birinchi sutkada odatda 321 ta ko‘rish yig‘iladi.
  • Reaksiyalar va o‘zaro ta’sir: Auditoriya faol: har bir postga o‘rtacha 2 ta reaksiya keladi.
  • Tematik yo‘nalishlar: Kontent module, general, microbiology, summary, بارا kabi asosiy mavzularga jamlangan.

📝 Tavsif va kontent siyosati

Muallif resursni shaxsiy fikrni ifoda etish maydoni sifatida ta’riflaydi:
Data Introduction Modules لمشاركة القناة - https://t.me/Introduction_Modules البوت - https://t.me/Introduction_ModulesBot القناة الرئيسية - @Medicine_Way2

Yuqori yangilanish chastotasi (oxirgi ma’lumot 01 Sentabr, 2026 da olingan) sababli kanal doimo dolzarb va katta qamrovli bo‘lib qoladi. Analitika auditoriya kontent bilan faol hamkorlik qilishini, uni Tibbiyot toifasidagi muhim ta’sir nuqtasiga aylantirishini ko‘rsatadi.

27 086
Obunachilar
+1224 soatlar
+2647 kun
+88530 kun
Postlar arxiv
22 - Revision of L11, Thrombosis, Embolism, Hemorrhage and Shock, Pathology.mp4 Quality : 🎬 480p

20 - Revision of L 10, Ischemic, Infarction , Hyperemia and congestion, Pathology.mp4 Quality : 🎬 480p

19 - Revision of Tut1 part2 , Granuloma , Pathology.mp4 Quality : 🎬 480p

18 - Revision of L9 , Granuloma (Bilharziasis), Pathology.mp4 Quality : 🎬 480p

17 - Revision of L7,8 , Chronic inflammation & Granuloma (TB) , Pathology.mp4 Quality : 🎬 480p

11 - Revision of L6, Types of acute inflammation, pathology.mp4 Quality : 🎬 480p

10 - Revision of L4, Cellular accumulation , pathology.mp4 Quality : 🎬 480p

9 - Revision of L3, Irreversible cell injury, pathology.mp4 Quality : 🎬 480p

7 - Revision of L5, Acute Inflammation, pathology.mp4 Quality : 🎬 480p

6 - Revision of L1, Cellular adaptation and disturbance of growth, Pathology.mp4 Quality : 🎬 480p

5 - Revision of L2, Reversible cell injury, Pathology.mp4 Quality : 🎬 480p

مراجعه نجاح بدون جشع باثو 👇👇 #Pathology

36 - Revision of L4, General Mycology, Microbiology.mp4 Quality : 🎬 480p

34 - Revision of L5,6 &Tut3, general virology + hospital acquired infection,Microbiology.mp4 Quality : 🎬 480p

32 - Revision of Tut 4, Needle stick injury, Microbiology.mp4 Quality : 🎬 480p

31 - Revision of L6, General virology 2, Microbiology.mp4 Quality : 🎬 480p

30 - Revision of L5, General Virology, Microbiology.mp4 Quality : 🎬 480p

27 - Revision of L3, Antimicrobial agents, Microbiology.mp4 Quality : 🎬 480p

26 - Revision of Tut 3, Nosocomial infection, Microbiology.mp4 Quality : 🎬 480p

16 - Revision of L2 Bacterial genetics, Microbiology.mp4 Quality : 🎬 480p